Akciğerlerde Akut Radyasyon Hasarı
Özet
İyonlaştırıcı radyasyon, nükleer kazalar veya silahlar sonucu tüm canlı dokulara zarar vererek Akut Radyasyon Sendromu (ARS) tablosuna yol açmaktadır. Bu süreçte solunum sistemi, özellikle de yapısal hassasiyeti yüksek olan akciğerler, radyasyona karşı en duyarlı organ grupları arasında yer almaktadır. Akut maruziyet sonrasında hücre içi DNA hasarı ve reaktif oksijen türlerinin (ROS) hızla artması, erken dönemde geri dönüşümlü radyasyon pnömonisine, uzun vadede ise geri dönüşü olmayan doku fibrozisi, kronik obstrüktif tıkanıklıklar ve malignitelere zemin hazırlamaktadır. Tarihteki Çernobil ve Fukuşima gibi majör nükleer felaketler ile ülkemizde yaşanan İkitelli kazası, ARS gelişiminin klinik boyutlarını ve solunum sistemi üzerindeki yıkıcı etkilerini somut şekilde gözler önüne sermiştir. İlk 48 saatte METROPOL skorlama sistemiyle hasar düzeyinin belirlenmesi, nötropenik süreçlerde anaerobik florayı koruyan doğru antimikrobiyal rejimlerin seçilmesi ve interstisyel fibrozis gelişen hastalarda steroid tedavisine başlanması kritik yönetim adımlarıdır. Sonuç olarak, radyasyon hasarının erken teşhisi ve komplikasyon yönetimi, sağlık profesyonellerinin yapılandırılmış acil durum protokollerini titizlikle uygulamasıyla optimize edilebilir.
Ionizing radiation, resulting from nuclear accidents or weapons, inflicts severe damage on living tissues, leading to Acute Radiation Syndrome (ARS). During this process, the respiratory system, particularly the highly sensitive lungs, stands out as one of the most vulnerable organ groups to radiation. Following acute exposure, intracellular DNA damage and the rapid increase of reactive oxygen species (ROS) trigger reversible radiation pneumonitis in the early phase, while paving the way for irreversible tissue fibrosis, chronic obstructive disorders, and malignancies in the long term. Major historical nuclear disasters such as Chernobyl and Fukushima, along with the Ikitelli accident in Turkey, clearly demonstrate the clinical dimensions of ARS and its devastating effects on the respiratory tract. Determining the damage level within the first 48 hours using the METROPOL scoring system, selecting appropriate antimicrobial regimens that preserve the anaerobic flora in neutropenic stages, and initiating steroid therapy for patients developing interstitial fibrosis represent critical management steps. Consequently, early diagnosis and complication management of radiation injury can be optimized through the meticulous implementation of structured emergency protocols by healthcare professionals.
Referanslar
Chao NJ. Accidental or intentional exposure to ionizing radiation: biodosimetry and treatment options. Experimental hematology. 2007;35(4):24-27.
URL. https://www.cdc.gov/nceh/radiation/emergencies/ars.htm. Erişim Tarihi: 14102021.
MacVittie TJ, Farese AM, Parker GA, et al. The time course of radiation-induced lung injury in a nonhuman primate model of partial-body irradiation with minimal bone marrow sparing: clinical and radiographic evidence and the effect of neupogen administration. Health physics. 2019;116(3):366-382.
Donnelly EH, Nemhauser JB, Smith JM, et al. Acute radiation syndrome: assessment and management. South Med J. 2010;103(6):541-546.
Hill R. Radiation effects on the respiratory system. The British Journal of Radiology. 2005(1):75-81.
Medhora M, Gao F, Jacobs ER, et al. Radiation damage to the lung: Mitigation by angiotensin‐converting enzyme (ACE) inhibitors. Respirology. 2012;17(1):66-71.
Araya J, Maruyama M, Sassa K, et al. Ionizing radiation enhances matrix metalloproteinase-2 production in human lung epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2001;280(1):L30-L38.
Azzam EI, Jay-Gerin J-P, Pain D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer letters. 2012;327(1-2):48-60.
Jack CI, Bottier B, Jackson MJ, et al. Indicators of free radical activity in patients developing radiation pneumonitis. International Journal of Radiation Oncology* Biology* Physics. 1996;34(1):149-154.
Giuranno L, Ient J, De Ruysscher D, et al. Radiation-induced lung injury (RILI). Frontiers in oncology. 2019;9:877.
Liu X, Chen Z. The pathophysiological role of mitochondrial oxidative stress in lung diseases. Journal of Translational Medicine. 2017;15(1):1-13.
Fleckenstein K, Zgonjanin L, Chen L, et al. Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. International Journal of Radiation Oncology* Biology* Physics. 2007;68(1):196-204.
Cui W, Zhang P, Hankey KG, et al. AEOL 10150 Alleviates Radiation-induced Innate Immune Responses in Non-human Primate Lung Tissue. Health Physics. 2021;121(4):331-344.
Grobova O, Chernikov V. The presence of cesium-137 in the tissue of a lung tumor in someone who cleaned up the aftermath of the accident at the Chernobyl Atomic Electric Power Station. Terapevticheskii arkhiv. 1996;68(3):26-30.
Chizhikov V, Chikina S, Gasparian A, et al. Molecular follow-up of preneoplastic lesions in bronchial epithelium of former Chernobyl clean-up workers. Oncogene. 2002;21(15):2398-2405.
URL. (https://www.bbc.com/news/world-asia-45423575). Erişim Tarihi: 14102021.
Tkachishin V. Clinical course of chronic bronchitis in Chernobyl wreckers. Terapevticheskii arkhiv. 2000;72(11):59-61.
Pikas O. Fatty acid lipid spectrum in the expired air condensate of persons exposed to moderate-dosage ionizing radiation at the Chernobyl atomic power station. Problemy tuberkuleza. 2002(3):48-50.
Poliakova V, Suchko V, Tereshchenko V, et al. Invasion of microorganisms in bronchial mucosa of liquidators of the Chernobyl accident consequences. Mikrobiolohichnyi zhurnal (Kiev, Ukraine: 1993). 2001;63(1):41-50.
SIu C, BKh I, Kopylev I, et al. N-Acetylcysteine: low and high doses in the treatment of chronic obstructive lung diseases in Chernobyl accident liquidators. Terapevticheskii arkhiv. 2002;74(3):62-65.
Mettler Jr FA, Gus’kova AK, Gusev I. Health effects in those with acute radiation sickness from the Chernobyl accident. Health physics. 2007;93(5):462-469.
Palma DA, Senan S, Tsujino K, et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. International Journal of Radiation Oncology* Biology* Physics. 2013;85(2):444-450.
Sekine I, Sumi M, Ito Y, et al. Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients. Radiotherapy and oncology. 2006;80(1):93-97.
Ikezoe J, Takashima S, Morimoto S, et al. CT appearance of acute radiation-induced injury in the lung. American Journal of Roentgenology. 1988;150(4):765-770.
Yamashita H, Kobayashi-Shibata S, Terahara A, et al. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy. Radiation oncology (London, England). 2010;5:32.
Wiwanitkit V. Pulmonary disorder and present nuclear denotation: A brief summary. Annals of thoracic medicine. 2011;6(3):107.
Sakurai M, Takahashi T, Ohuchi M, et al. Increasing Incidence of Tuberculosis Infection in the Coastal Region of Northern Miyagi after the Great East Japan Earthquake. The Tohoku Journal of Experimental Medicine. 2016;238(3):187-195.
Shimouchi A, Kobayashi N, Nagata Y, et al. The influence of the Great East Japan Earthquake on tuberculosis control in Japan. Western Pac Surveill Response J. 2015;6(4):30-32.
Kalechits OM, Al'khimovich VA. [Tuberculosis and the Chernobyl tragedy: status and prognosis]. Problemy tuberkuleza. 1990(11):14-16.
Nair V, Karan D, Makhani C. Guidelines for medical management of nuclear/radiation emergencies. Medical Journal Armed Forces India. 2017;73(4):388-393.
Alagoz E, editor Basic Concepts in Intervention of Nuclear, Radiological Injuries, Acute Radiation Syndrome and Its Treatment/Nukleer Radyolojik Acillere Mudahalede Temel Kavramlar, Akut Radyasyon Sendromu ve Tedavisi. Nuclear Medicine Seminars; 2017: Galenos Yayinevi Tic. Ltd.
Xiao M, Whitnall MH. Pharmacological countermeasures for the acute radiation syndrome. Current molecular pharmacology. 2009;2(1):122-133.
